Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Catalyst Biosciences To Drop Lab-Made Clotting Factor
Description
Catalyst Biosciences ($CBIO@US) has decided to halt the clinical development of its lab-made clotting factor to prevent acute bleeds in hemophilia patients with inhibitors. It will now focus solely on complement programs and protease medicines platforms. The company said that trials for the treatment have been adversely impacted by pandemic-related logistical challenges, competition, and the increasing therapies available. Catalyst also reports that halting development will allow it to reduce the burn rate by approximately 40%. The company plans to advance the clinical development of CB 4332, a protein that could eventually be used to restore and rebalance the root cause of an ultra-rare disorder that affects the immune system. Cash, cash equivalents, and investments for the third quarter stood at $64.5 million. Shares slipped 33% at a 52-week low of $1.97 during the premarket session last Friday.
Keywords & Tags
#finance
#biotech
#inflation
#business
#economic recovery
#biopharmaceutical company
#medicine
#pharmaceutical
#prescription drugs
#economic growth
#pharmacy
#economic outlook
#Catalyst Biosciences
#Lab-Made Clotting Factor
#clinical development
#prevent acute bleeds
#hemophilia patients
#inhibitors
#CB 4332
#ultra-rare disorder
#immune system
#protein
#hematology indications
#drug RD company
#engineered human proteases
#CBIO
More from User
01:03
Microsoft Cuts 4,800 Jobs
Benzinga
00:56
Toyota Shifts Tacoma To Texas
Benzinga
01:00
Lucid Rides EV Momentum
Benzinga
00:54
Klarna Seeks Bank Charter
Benzinga
00:57
Chinese AI Gains In U.S.
Benzinga
00:52
AI Credit Wars Heat Up
Benzinga
Related Videos
01:09
How a blood clot forms - Blood clotting Mechanism and Physiology
HEALTH INFO NETWORK
02:03
Blood Clotting In Legs: Pair Me Blood Clot Kyu Hota Hai,खून के थक्के जमने के क्या लक्षण हैं |Boldsky
Boldsky
00:07
Mathematical Epidemiology (Lecture Notes in Mathematics / Mathematical Biosciences Subseries)
2wtvfz
03:08
Kent Biosciences hails unprecedented milestone in coronavirus vaccine
KentOnline / KMTV
02:19
Cadarache : qu'est-ce que le BIAM, l'Institut de biosciences et biotechnologies d'Aix-Marseille ?
D!CI TV
00:32
Anthem Biosciences IPO_ 🚀 Strong Market
prashant soni